申请人:GLAXO GROUP LTD
公开号:WO2012067663A1
公开(公告)日:2012-05-24
The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.
本发明涉及式(I)的化合物及其盐,包括所述化合物的药物组合物,以及利用这些化合物治疗或预防病毒感染,如HCV感染,以及与此类感染相关的疾病。